4D44 | pdb_00004d44

Crystal structure of S. aureus FabI in complex with NADP and 5-ethyl- 4-fluoro-2-((2-fluoropyridin-3-yl)oxy)phenol


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.80 Å
  • R-Value Free: 
    0.170 (Depositor), 0.190 (DCC) 
  • R-Value Work: 
    0.140 (Depositor), 0.165 (DCC) 
  • R-Value Observed: 
    0.142 (Depositor) 

Starting Model: experimental
View more details

wwPDB Validation 3D Report Full Report

Validation slider image for 4D44

Ligand Structure Quality Assessment 


This is version 1.2 of the entry. See complete history

Literature

An Ordered Water Channel in Staphylococcus Aureus Fabi: Unraveling the Mechanism of Substrate Recognition and Reduction.

Schiebel, J.Chang, A.Merget, B.Bommineni, G.R.Yu, W.Spagnuolo, L.A.Baxter, M.V.Tareilus, M.Tonge, P.J.Kisker, C.Sotriffer, C.A.

(2015) Biochemistry 54: 1943

  • DOI: https://doi.org/10.1021/bi5014358
  • Primary Citation Related Structures: 
    4D41, 4D42, 4D43, 4D44, 4D45, 4D46

  • PubMed Abstract: 

    One third of all drugs in clinical use owe their pharmacological activity to the functional inhibition of enzymes, highlighting the importance of enzymatic targets for drug development. Because of the close relationship between inhibition and catalysis, understanding the recognition and turnover of enzymatic substrates is essential for rational drug design. Although the Staphylococcus aureus enoyl-acyl carrier protein reductase (saFabI) involved in bacterial fatty acid biosynthesis constitutes a very promising target for the development of novel, urgently needed anti-staphylococcal agents, the substrate binding mode and catalytic mechanism remained unclear for this enzyme. Using a combined crystallographic, kinetic, and computational approach, we have explored the chemical properties of the saFabI binding cavity, obtaining a consistent mechanistic model for substrate binding and turnover. We identified a water-molecule network linking the active site with a water basin inside the homo-tetrameric protein, which seems to be crucial for the closure of the flexible substrate binding loop as well as for an effective hydride and proton transfer during catalysis. On the basis of our results, we also derive a new model for the FabI-ACP complex that reveals how the ACP-bound acyl-substrate is injected into the FabI binding crevice. These findings support the future development of novel FabI inhibitors that target the FabI-ACP interface leading to the disruption of the interaction between these two proteins.


  • Organizational Affiliation
    • †Institute of Pharmacy and Food Chemistry, University of Wuerzburg, Am Hubland, D-97074 Wuerzburg, Germany.

Macromolecule Content 

  • Total Structure Weight: 258.94 kDa 
  • Atom Count: 18,237 
  • Modeled Residue Count: 2,032 
  • Deposited Residue Count: 2,256 
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTASE [NADPH]
A, B, C, D, E
A, B, C, D, E, F, G, H
282Staphylococcus aureus subsp. aureus N315Mutation(s): 1 
EC: 1.3.1.10 (PDB Primary Data), 1.3.1.39 (PDB Primary Data)
UniProt
Find proteins for A0A0J9X1Y0 (Staphylococcus aureus (strain N315))
Explore A0A0J9X1Y0 
Go to UniProtKB:  A0A0J9X1Y0
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupA0A0J9X1Y0
Sequence Annotations
Expand
Reference Sequence

Small Molecules

Ligands 4 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
NAP

Query on NAP



Download:Ideal Coordinates CCD File
AA [auth F]
DA [auth G]
I [auth A]
JA [auth H]
L [auth B]
AA [auth F],
DA [auth G],
I [auth A],
JA [auth H],
L [auth B],
P [auth C],
U [auth D],
V [auth E]
NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE
C21 H28 N7 O17 P3
XJLXINKUBYWONI-NNYOXOHSSA-N
JA3

Query on JA3



Download:Ideal Coordinates CCD File
EA [auth G]
FA [auth G]
K [auth A]
M [auth B]
Q [auth C]
EA [auth G],
FA [auth G],
K [auth A],
M [auth B],
Q [auth C],
R [auth C],
W [auth E],
X [auth E]
5-ethyl-4-fluoro-2-[(2-fluoropyridin-3-yl)oxy]phenol
C13 H11 F2 N O2
BJEMGBNLIALWCL-UHFFFAOYSA-N
GLU

Query on GLU



Download:Ideal Coordinates CCD File
BA [auth F]
HA [auth G]
LA [auth H]
N [auth B]
S [auth C]
BA [auth F],
HA [auth G],
LA [auth H],
N [auth B],
S [auth C],
Y [auth E]
GLUTAMIC ACID
C5 H9 N O4
WHUUTDBJXJRKMK-VKHMYHEASA-N
MRD

Query on MRD



Download:Ideal Coordinates CCD File
CA [auth F]
GA [auth G]
IA [auth G]
J [auth A]
KA [auth H]
CA [auth F],
GA [auth G],
IA [auth G],
J [auth A],
KA [auth H],
O [auth B],
T [auth C],
Z [auth E]
(4R)-2-METHYLPENTANE-2,4-DIOL
C6 H14 O2
SVTBMSDMJJWYQN-RXMQYKEDSA-N
Binding Affinity Annotations 
IDSourceBinding Affinity
JA3 BindingDB:  4D44 IC50: 13 (nM) from 1 assay(s)

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.80 Å
  • R-Value Free:  0.170 (Depositor), 0.190 (DCC) 
  • R-Value Work:  0.140 (Depositor), 0.165 (DCC) 
  • R-Value Observed: 0.142 (Depositor) 
Space Group: P 1
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 89.97α = 98.06
b = 94.74β = 97.38
c = 94.8γ = 112.18
Software Package:
Software NamePurpose
REFMACrefinement
iMOSFLMdata reduction
SCALAdata scaling
PHASERphasing

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History 

Deposition Data

Revision History  (Full details and data files)

  • Version 1.0: 2015-03-04
    Type: Initial release
  • Version 1.1: 2015-04-15
    Changes: Database references
  • Version 1.2: 2023-12-20
    Changes: Data collection, Database references, Derived calculations, Other, Refinement description